Autonomix Medical, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Autonomix Medical, Inc. announced its annual stockholder meeting to vote on director elections, auditor ratification, a reverse stock split, an equity incentive plan, and a significant stock issuance.
NASDAQ
Autonomix Medical, Inc. will hold its Annual Meeting to vote on a reverse stock split, an expanded equity incentive plan, and a $15 million capital raise agreement with Lincoln Park Capital.
NASDAQ
Autonomix Medical, Inc. is holding its annual meeting of stockholders on October 17, 2024, to elect directors, ratify the appointment of auditors, and approve a potential reverse stock split.
NASDAQ
Autonomix Medical is holding its annual meeting on October 17, 2024, seeking stockholder approval for a reverse stock split, the election of five board nominees, and the ratification of its independent auditor.